initi coverag narrow moat stabl
updat forecast estim apr
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim apr
price data apr
rate updat apr
currenc amount express
valuat growth profit
methodolog valu compani
believ manag invest strategi
instrument form narrow-moat enterpris deploy
capit intern initi acquisit fortifi firm
posit global leader infect prevent firm
purchas isomedix form foundat upon
compani built lead posit contract steril servic
within healthcar industri cap acquisit
 -base synergi health think piec
busi repres widest-moat segment firm
switch cost regulatori intang provid materi
barrier dissuad custom switch steril
provid elsewher compani view healthcar
product life scienc busi convincingli narrow-moat
consum surgic suit biopharma manufactur
plant benefit embed switch cost
associ long-liv capit equip bud
busi think manag abl improv margin
time right-siz
invest continu
consolid fragment industri
franchis sell steril
ultim think firm posit give convinc
opportun earn return excess cost capit
come decad estim manag abl
consist earn mid-teen return invest capit
enterpris number mute recent year addit
synergi health cost integr begin fade
believ firm like return histor level econom
profit gener driven substanti margin improv
manag work prune compani busi
portfolio divest no-margin linen busi
primari driver expect near-term cost improv beyond
anticip firm abl sustain basi point
annual margin expans drive acceler
forecast period
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
plc -base medic devic compani focus steril
servic infect prevent compani global leader
contract steril servic ensur safe deliveri single-us
implant medic equip hospit around world addit
sell steril washer-disinfector decontamin
equip suppli use care provid facil within
bio-pharma manufactur site domicil prior
invers firm continu deriv roughli revenu
oper remain
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
initi coverag narrow moat
initi coverag -base
healthcar equip firm narrow moat stabl
trend rate estim fair valu per share
put share solidli territori impli
multipl time time forecast fiscal
adjust earn ebitda respect
lead player global infect prevent
market provid mix equip servic
ensur steril disinfect decontamin
product devic use surgic suit firm
competit advantag stem switch cost
present healthcar product life scienc
segment well appli steril technolog
busi area quit close link overal
healthcar util trend larg insul
price pressur seen elsewher sector
furthermor more-or-less indiffer chang
care
deliv -- firm benefit
procedur done either inpati outpati set
place uniqu strong posit benefit
increas volum driven demograph tailwind
time
compani tail end integr synergi health
largest acquisit firm histori spend
year wring excess cost prune
result portfolio pois reap benefit
transact
line return firm abl gener
prior tie synergi
valuat growth profit apr
initi fair valu estim
equat roughli time time estim
fiscal adjust earn ebitda respect
revenu expect roughli flat
report basi year year due asset divestitur
forecast organ revenu growth averag roughli
forecast period think earn sustain grow
low-double-digit rang time revenu growth
margin improv accret acquisit help
bolster firm bottom line expect gross margin
improv roughli basi point come five
year oper margin expand nearli basi
point outsiz oper leverag driven
reduct one-off cost associ integr
effort partial off-set modest acceler research
develop activ ultim think
culmin termin oper margin roughli
net margin approxim metric
somewhat higher firm earn
normal basi histor support
improv revenu mix post-synergi acquisit given
expans firm higher margin ast franchis
given firm steadi growth cash flow give
forecast call roughli organ growth
annual basi aid margin improv drive mid-
teen earn compound-annual-growth-rate margin expans
result sale low margin non-core asset
along integr cost begin drop
come year assumpt result return capit
eclips averag net-of-goodwil basi
bull-cas scenario forecast organ revenu
growth roughli basi point ahead base case
forecast period given healthi margin
expans forecast base-cas scenario bull
case incorpor modest upsid base-cas
expect result oper margin near
similarli net margin predict fall near
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
segment healthcar product life scienc sell similar
technolog two separ end market
busi view deserv narrow moat rate
posit well continu provid key servic
firm ast segment view one
interest aspect compani would like deserv
wide-moat rate oper stand-alone entiti
segment one global busi focus
steril singl use implant medic
suppli prior deliveri use within hospit
surgic set industrywid basi
effect two mechan suppli
steril today -- gamma radiat ga treatment
manag posit firm roughli
equal exposur two modal modest tilt
toward radiat segment revenu think
attract busi multitud reason -- high
util structur growth driver duopoli structur
combin creat strong growth high margin ration
price addit extrem high cost failur
rel low contribut overal devic cost mean
product manufactur littl incent switch
vendor implant sutur needl caus
unnecessari infect potenti fda mandat
recal brand impair physician backlash would far
outpac small price benefit attain switch
nascent competitor steril cost less
cost manufactur incur product transport
help illustr true lack incent pursu
price concess area final steri
custom year contract busi show
remark stabil help gener cash
manag abl invest across compani
acquisit synergi health posit
final year model assumpt result
fair valu estim per share time
time bull-cas forecast fiscal adjust
earn ebitda respect
meaning recent trend impli averag
growth rate forecast period closer
scenario expect price pressur acceler result
gross margin forecast declin roughli
basis-point result oper
margin declin modestli end
forecast period termin net margin line
peak margin perform busi histor
bear case assumpt culmin fair valu
estim per share time lower
forecast adjust earn ebitda respect
develop narrow moat underpin
embed custom switch cost ultim view
appli steril technolog ast segment
moatiest aspect firm healthcar specialti
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
clear number one global contract steril
former intern busi compliment firm
legaci number two posit
benefit
healthcar product life scienc segment
steri
century-long tenur global infect prevent along
long-liv capit equip provid repeat
consum sale servic
requir
dissuad frequent replac stack
global leader steril servic product line
encompass steam hydrogen peroxid chemic
steril base equip reprocess
endoscop surgic suppli year product
live hospit set firm abl drive
signific lifetim custom valu one
system placement altern firm sale
bio-pharma end market encapsul custom
project order conjunct expans
manufactur capac vaccin biolog
order rang hundr thousand
low-single-digit million dollar valu central
safe effici product product
environ regulatori intang also play
bio-pharma market fda inspect manufactur site
must maintain complianc written product
procedur risk taken offlin
final firm healthcar servic segment like
no-moat franchis predominantli instrument
repair busi maintain roughli one third
highli fragment market primari focu
repair endoscop surgic equip
low margin labor intens servic oper
interestingli firm nascent presenc
outsourc steril depart hospit
surgic center preval intern market
particularli rel new concept firm
bring healthcar provid whether take
manag on-site locat use in-hous
facil reprocess uniqu opportun
long runway growth pace chang
area like glacial expect firm consist
make inroad time
maintain stabl moat trend dont forese
much strengthen weaken within underli
switch cost moat sourc expect firm maintain
lead posit contract steril servic
expand lead tradit healthcar life
scienc market also anticip manag
return steadi pace privat tuck-in acquisit
synergi health fulli integr firm balanc
sheet return histor leverag level
like rout capit deploy continu roll
fragment devic repair servic industri
think add valu right price
unlik contribut expans firm moat given
segment no-moat characterist think
reason growth strategi pursu
wed normal expect biggest risk firm
moat brand impair due fda recal
qualiti breakdown lose custom trust way steri
handl fda recal platform give us
comfort manag abil navig crisi
confid quick approv replac platform
gener custom accommod allow overal
busi emerg fda consent decre rel
unscath compar compani find
regulatori scrutini addit
think manag current invest right
area wed consid neg moat trend steri
fall behind lead edg steril technolog
ast product busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
owith plan divestitur complet steri
better abl focu acceler organ
oth firm balanc sheet posit
allow manag return value-add acquisit
activ rather alloc excess cash debt
posit benefit continu growth
healthcar util broadli rel
unaffect transit
inpati
compet area healthcar seen
fair share product recal costli
compani custom patient
weigh result longer initi expect
owith passag corpor tax reform
lose much financi advantag gain
invers
ast busi highli reliant firm
abil replenish suppli
compani long-term suppli contract place
radioact materi suppli hand
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
manag proven prudent util
firm balanc sheet keep promis reduc debt
associ merger synergi health
estim firm took leverag level near time
adjust ebitda conjunct deal far beyond
compani pre-merg averag roughli time
year look like metric retreat
time rang reason under-leverag
narrow-moat enterpris believ
manag turn capit alloc prioriti away
debt reduct toward increas invest
potenti acquisit opportun come year
level financi flexibl enhanc strong
cash gener profil -- anticip firm
gener roughli million free cash flow fiscal year
set grow low-teen compound-annual-growth-rate
given firm predict driver revenu
equip sale believ warrant medium
uncertainti rate healthcar broadli continu
impact concern around excess price power
revenu base instead tie product volum
much stabl tend grow
mid-single-digit rang fairli consist whether
contract steril medic equip steril
consum sold surgic set servic
repair capit equip view larg
insul volatil seen elsewher
sector fact firm maintain presenc across
care set whether acut care hospit
ambulatori surgeri center age popul
provid sustain growth tailwind regardless
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
creat grow free cash flow stream manag
abl alloc capit expenditur dividend
increas acquisit opportun
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
manag team togeth
decad demonstr substanti valu creation
intens focu return valu sharehold via
dividend warrant exemplari stewardship rate
current ceo walter rosebrough skill shepherd
compani econom crisi sizabl product
recal ftc merger challeng keep
best interest sharehold mind
repres date owner name posit common share held report holder issuer
fidel manag research compani
share
fund
share
fund
central assess execut remain
solid firm transit strategi heavili
focus acquisit last five year
manag team priorit return invest capit
preemin measur valu creation mesh
well intern valuat methodolog
manag continu reinvest busi
need expand capac refresh long-cycl
product think priorit acquisit
opportun sharehold return prudent given
limit need substanti invest firm core
franchis cash flow continu grow anticip
well see ever-grow dividend bolt-on acquisit
primari use excess capit think sourc
valuat execut activ time
valu enhanc overal asid contribut
synergi health compani abl earn
consist mid-teen return capit time
includ goodwil contribut annual deal
think hallmark success capit deploy
turn compens think firm pay structur
adequ align manag incent
interest sharehold execut offic variabl
pay make total annual compens
major tie equity-link structur like
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
see addit annual incent bonus paid
base annual target oper incom free cash
flow two metric favor easili adjust
item ep howev wed like see
substanti insid ownership total director
offic cohort maintain roughli ownership
includ outright equiti near-term
final overli materi overal assess
think firm long-stand polici separ
ceo board chairman role help contribut
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
eclips averag net-of-goodwil basi
line return firm abl gener
prior tie synergi
initi coverag narrow moat
initi coverag -base
healthcar equip firm narrow moat stabl
trend rate estim fair valu per share
put share solidli territori impli
multipl time time forecast fiscal
adjust earn ebitda respect
lead player global infect prevent
market provid mix equip servic
ensur steril disinfect decontamin
product devic use surgic suit firm
competit advantag stem switch cost
present healthcar product life scienc
segment well appli steril technolog
busi area quit close link overal
healthcar util trend larg insul
price pressur seen elsewher sector
furthermor more-or-less indiffer chang
care
deliv -- firm benefit
procedur done either inpati outpati set
place uniqu strong posit benefit
increas volum driven demograph tailwind
time
compani tail end integr synergi health
largest acquisit firm histori spend
year wring excess cost prune
result portfolio pois reap benefit
transact
forecast call roughli organ growth
annual basi aid margin improv drive mid-
teen earn compound-annual-growth-rate margin expans
result sale low margin non-core asset
along integr cost begin drop
come year assumpt result return capit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end march
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end march
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
